What was the strategy behind the CareScience acquisition and what functionality is it enhancing for Quovadx?
Ronald: First, as you might expect, the Quovadx strategy behind CareScience was really multifactorial. To begin with, care science represents a strong brand in the clinical analysis, clinical process enhancement, and clinical data sharing market segment. Second, the acquisition was really a natural progression of what had been a previously articulated Quovadx strategy of building or acquiring adaptive applications to take advantage of Quovadx underlying technology platform. As health care organizations increasingly begin to focus on the clinical aspects of their operations, it is critical for Quovadx to have even more of that kind of internal expertise as part of their broader company healthcare strategy. So, CareScience really offered not only its existing technology base from its products but also a key group of clinical and related staff to support those broader objectives. I think CareSciences future development plans require that we focus directly on the underlying real time data
